Nifedipine potentiates the antinociceptive effect of endomorphin-1 microinjected into the periaqueductal gray in rats

Anesthesia and Analgesia

Volumn 96, Issue 4, 2003, Pages 1065-1071

  Hao, Shuanglin ^a,b,c   Mamiya, Keiko ^a   Takahata, Osamu ^a   Iwasaki, Hiroshi ^a   Mata, Marina ^b   Fink, David J ^b  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOMORPHIN 1; NIFEDIPINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENTIATION; MICROINJECTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; AREA UNDER CURVE; BEHAVIOR, ANIMAL; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROINJECTIONS; NALTREXONE; NARCOTIC ANTAGONISTS; NIFEDIPINE; OLIGOPEPTIDES; PAIN MEASUREMENT; PERIAQUEDUCTAL GRAY; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME;

EID: 0037378618     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Mohrland JS, McManus DQ, Gebhart GF. Lesions in nucleus reticularis gigantocellularis: effect on the antinociception produced by micro-injection of morphine and focal electrical stimulation in the periaqueductal gray matter. Brain Res 1982;231: 143-52.
2. Jensen TS, Yaksh TL. Comparison of the antinociceptive action of mu and delta opioid receptor ligands in the periaqueductal gray matter, medial and paramedial ventral medulla in the rat as studied by the microinjection technique. Brain Res 1986;372: 301-12.
3. Smith DJ, Perrotti JM, Crisp T, et al. The mu opiate receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat brain. Eur J Pharmacol 1988;156:47-54.
4. Akil H, Mayer DJ, Liebeskind JC. Antagonism of stimulation-produced analgesia by naloxone, a narcotic antagonist. Science 1976;191:961-2.
5. Zadina JE, Hackler L, Ge LJ, Kastin AJ. A potent and selective endogenous agonist for the μ-opiate receptor. Nature 1997;386: 499-502.
6. Goldberg IE, Rossi GC, Letchworth SR, et al. Pharmacological characterization of endomorphin-1 and endomorphin-2 in mouse brain. J Pharmacol Exp Ther 1998;286:1007-13.
7. Martin-Schild S, Gerall AA, Kastin AJ, Zadina JE. Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol 1999; 405:450-71.
8. 2+ channels and their role in neurotransmitter release. Cell Calcium 1998;24: 307-23.
9. Perney TM, Hirning LD, Leeman SE, Miller RJ. Multiple calcium channels mediate neurotransmitter release from peripheral neurons. Proc Natl Acad Sci U S A 1986;83:6656-9.
10. Hao S, Takahata O, Iwasaki H. Electroacupuncture potentiates the antinociceptive effect of intrathecal endomorphin-1 in the rat formalin test. Neurosci Lett 2000;287:9-12.
11. Wong CH, Wu WH, Zbuzek VK. Hypotension does not alter the antinociceptive effect of nifedipine. Life Sci 1998;63:PL343-8.
12. Miranda HF, Pelissier T, Sierralta F. Analgesic effects of intracerebroventricular administration of calcium channel blockers in mice. Gen Pharmacol 1993;24:201-4.
13. al-Humayyd MS. Effect of diltiazem, nifedipine and verapamil on the antinociceptive action of acetylsalicylic acid in mice. Gen Pharmacol 1991;22:121-5.
14. Pavone F, Battaglia M, Sansone M. Nifedipine-morphine interaction: a further investigation on nociception and locomotor activity in mice. J Pharm Pharmacol 1992;44:773-6.
15. Carta F, Bianchi M, Argenton S, Cervi D. Effect of nifedipine on morphine-induced analgesia. Anesth Analg 1990;70:493-8.
16. Lovick TA. Integrated activity of cardiovascular and pain regulatory systems: role in adaptive behavioural responses. Prog Neurobiol 1993;40:631-44.
17. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic Press, 1986.
18. Tiseo PJ, Inturrisi CE. Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY-274614. J Pharmacol Exp Ther 1993;264:1090-6.
19. Stamford JA. Descending control of pain. Br J Anaesth 1995;75: 217-27.
20. Bonica JJ. Biochemistry and modulation of nociception and pain. In: Bonica JJ, ed. The management of pain. Philadelphia: Lea & Febiger, 1990:95-121.
21. Tempel A, Zukin RS. Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc Natl Acad Sci U S A 1987;84:4308-12.
22. Mansour A, Fox CA, Burke S, et al. Immunocytochemical localization of cloned mu opioid receptor in the rat CNS. J Chem Neuroanat 1995;8:283-305.
23. Chieng B, Christie MJ. Hyperpolarization by opioids acting on mu-receptors of a sub-population of rat periaqueductal gray neurones in vitro. Br J Pharmacol 1994;113:121-8.
24. Tracey I, Ploghaus A, Gati JS, et al. Imaging attentional modulation of pain in the periaqueductal gray in humans. J Neurosci 2002;22:2748-52.
25. Corbett AD, Paterson SJ, Kosterlitz HW. Selectivity of ligands for opioid receptors. In: Herz A, ed. Handbook of experimental pharmacology, opioids. I. New York: Springer, 1993:645.
26. Narita M, Mizoguchi H, Narita M, et al. G protein activation by endomorphins in the mouse periaqueductal gray matter. J Biomed Sci 2000;7:221-5.
27. Bustamante D, Miranda HF, Pelissier T, Paeile C. Analgesic action of clonixin, nifedipine and morphine using the formalin test. Gen Pharmacol 1989;20:319-22.
28. 2+ channel antagonists on morphine analgesia, tolerance and dependence, and on blood pressure in the rat. Eur J Pharmacol 1998;352:189-97.
29. 2+ channels in GH3 cells by cloned mu- and delta-opioid receptors. Mol Pharmacol 1996;50:947-56.
30. Guerrero-Munoz F, Adames C, Fearon Z, Way EL. Calcium-opiate antagonism in the periaqueductal grey (PGA) region. Eur J Pharmacol 1981;76:417-9.
31. Dogrul A, Yesilyurt O, Isimer A, Guzeldemir ME. L-type and T-type calcium channel blockade potentiate the analgesic effects of morphine and selective mu opioid agonist, but not to selective delta and kappa agonist at the level of the spinal cord in mice. Pain 2001;93:61-8.
32. Connor M, Schuller A, Pintar JE, Christie MJ. Mu-opioid receptor modulation of calcium channel current in periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1. Br J Pharmacol 1999;126:1553-8.
33. Yamamoto HA, McCain HW, Misawa S, Way EL. Effects of amino acids, especially taurine and gamma-aminobutyric acid (GABA), on analgesia and calcium depletion induced by morphine in mice. Eur J Pharmacol 1981;71:177-84.
34. 2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J Physiol 1998;509:47-58.
35. 2+ channels in the rat periaqueductal gray neurons by mu-type opioid agonist. J Neurophysiol 1997;77:1418-24.